<html>
<head>
<title>Utah Legislature HB0395</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>CONTROLLED SUBSTANCE DATABASE AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2015 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  Edward H. Redd</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill modifies provisions of the Controlled Substance Database Act.<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires the Division of Occupational and Professional Licensing to implement a<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;program for:<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;real-time submission of data into the controlled substance database; and<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;24-hour daily batch submission of data;<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;authorizes additional rulemaking authority;<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provides that those accessing data from the database are responsible for costs<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;associated with accessing the data;<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;repeals provisions of a pilot program; and<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical corrections.<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill appropriates in fiscal year 2016:<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to the Department of Commerce - Division of Occupational and Professional<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Licensing - Controlled Substance Database, as an ongoing appropriation:<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8226;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the General Fund, $46,000.<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill provides a special effective date.<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-203">58-37f-203</a></b>, as last amended by Laws of Utah 2014, Chapter 72<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-301">58-37f-301</a></b>, as last amended by Laws of Utah 2014, Chapters 68 and 401<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-501">58-37f-501</a></b>, as enacted by Laws of Utah 2010, Chapter 287 and last amended by<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Coordination Clause, Laws of Utah 2010, Chapter 287<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;REPEALS:<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-801&session=2015GS">58-37f-801</a></b>, as last amended by Laws of Utah 2013, Chapter 167<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>58-37f-203</b><a name="58-37f-203"></a> is amended to read:<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-37f-203.</b>   <b>Submission, collection, and maintenance of data.</b><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1) (a)  The division shall implement on a statewide basis, including non-resident</u><br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>pharmacies as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2015GS">58-17b-102</a>, a program of:</u><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  real-time submission of the information required to be submitted under this part to</u><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the controlled substance database; and</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  24-hour daily batch submission of the information required to be submitted under</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>this part to the controlled substance database.</u><br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.</u><br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(1)</strike>] <u>(2)</u> (a)  The pharmacist in charge of the drug outlet where a controlled substance is<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensed shall submit the data described in this section to the division:<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  in accordance with the requirements of this section;<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  in accordance with the procedures established by the division; and<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  in the format established by the division.<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  A dispensing medical practitioner licensed under Chapter 17b, Part 8, Dispensing<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, shall comply with<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the provisions of this section and the dispensing medical practitioner shall assume the duties of<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the pharmacist under this chapter.<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(2)</strike>] <u>(3)</u>  The pharmacist described in Subsection [<strike>(1)</strike>] <u>(2)</u> shall, for each controlled<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance dispensed by a pharmacist under the pharmacist's supervision other than those<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensed for an inpatient at a health care facility, submit to the division the following<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;information:<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  the name of the prescribing practitioner;<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  the date of the prescription;<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  the date the prescription was filled;<br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  the name of the individual for whom the prescription was written;<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  positive identification of the individual receiving the prescription, including the<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;type of identification and any identifying numbers on the identification;<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  the name of the controlled substance;<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  the quantity of the controlled substance prescribed;<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)  the strength of the controlled substance;<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the quantity of the controlled substance dispensed;<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)  the dosage quantity and frequency as prescribed;<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)  the name of the drug outlet dispensing the controlled substance;<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)  the name of the pharmacist dispensing the controlled substance; and<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)  other relevant information as required by division rule.<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(3) (a)</strike>] <u>(4)</u>  The division shall make rules, in accordance with Title 63G, Chapter 3,<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Utah Administrative Rulemaking Act, to establish <u>submission requirements under this part,</u><br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>including</u> the electronic format in which the information required under this section shall be<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;submitted to the division.<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(b)</strike>] <u>(5)</u>  The division shall ensure that the database system records and maintains for<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reference:<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(i)</strike>] <u>(a)</u>  the identification of each individual who requests or receives information from<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database;<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(ii)</strike>] <u>(b)</u>  the information provided to each individual; and<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[<strike>(iii)</strike>] <u>(c)</u>  the date and time that the information is requested or provided.<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  Section <b>58-37f-301</b><a name="58-37f-301"></a> is amended to read:<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-37f-301.</b>   <b>Access to database.</b><br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah<br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administrative Rulemaking Act, to:<br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  effectively enforce the limitations on access to the database as described in this<br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;part; and<br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  establish standards and procedures to ensure accurate identification of individuals<br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requesting information or receiving information without request from the database.<br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  The division shall make information in the database and information obtained from<br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;other state or federal prescription monitoring programs by means of the database available only<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to the following individuals, in accordance with the requirements of this chapter and division<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;rules:<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  personnel of the division specifically assigned to conduct investigations related to<br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance laws under the jurisdiction of the division;<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  authorized division personnel engaged in analysis of controlled substance<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescription information as a part of the assigned duties and responsibilities of their<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employment;<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  in accordance with a written agreement entered into with the department,<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employees of the Department of Health:<br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  whom the director of the Department of Health assigns to conduct scientific studies<br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;regarding the use or abuse of controlled substances, if the identity of the individuals and<br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pharmacies in the database are confidential and are not disclosed in any manner to any<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individual who is not directly involved in the scientific studies; or<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  when the information is requested by the Department of Health in relation to a<br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;person or provider whom the Department of Health suspects may be improperly obtaining or<br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;providing a controlled substance;<br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  in accordance with a written agreement entered into with the department, a<br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designee of the director of the Department of Health, who is not an employee of the<br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Department of Health, whom the director of the Department of Health assigns to conduct<br/>113&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scientific studies regarding the use or abuse of controlled substances pursuant to an application<br/>114&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;process established in rule by the Department of Health, if:<br/>115&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the designee provides explicit information to the Department of Health regarding<br/>116&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the purpose of the scientific studies;<br/>117&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the scientific studies to be conducted by the designee:<br/>118&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  fit within the responsibilities of the Department of Health for health and welfare;<br/>119&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  are reviewed and approved by an Institutional Review Board that is approved for<br/>120&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;human subject research by the United States Department of Health and Human Services; and<br/><hr>121&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)  are not conducted for profit or commercial gain; and<br/>122&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)  are conducted in a research facility, as defined by division rule, that is associated<br/>123&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a university or college in the state accredited by the Northwest Commission on Colleges<br/>124&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Universities;<br/>125&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the designee protects the information as a business associate of the Department of<br/>126&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Health; and<br/>127&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  the identity of the prescribers, patients, and pharmacies in the database are<br/>128&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;de-identified, confidential, not disclosed in any manner to the designee or to any individual<br/>129&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;who is not directly involved in the scientific studies;<br/>130&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)  in accordance with the written agreement entered into with the department and the<br/>131&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Department of Health, authorized employees of a managed care organization, as defined in 42<br/>132&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C.F.R. Sec. 438, if:<br/>133&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the managed care organization contracts with the Department of Health under the<br/>134&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provisions of Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-18-405&session=2015GS">26-18-405</a> and the contract includes provisions that:<br/>135&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  require a managed care organization employee who will have access to information<br/>136&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the database to submit to a criminal background check; and<br/>137&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) limit the authorized employee of the managed care organization to requesting either<br/>138&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the division or the Department of Health to conduct a search of the database regarding a<br/>139&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;specific Medicaid enrollee and to report the results of the search to the authorized employee;<br/>140&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and<br/>141&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the information is requested by an authorized employee of the managed care<br/>142&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;organization in relation to a person who is enrolled in the Medicaid program with the managed<br/>143&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;care organization, and the managed care organization suspects the person may be improperly<br/>144&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;obtaining or providing a controlled substance;<br/>145&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)  a licensed practitioner having authority to prescribe controlled substances, to the<br/>146&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;extent the information:<br/>147&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) (A)  relates specifically to a current or prospective patient of the practitioner; and<br/>148&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  is provided to or sought by the practitioner for the purpose of:<br/>149&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(I)  prescribing or considering prescribing any controlled substance to the current or<br/>150&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prospective patient;<br/>151&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(II)  diagnosing the current or prospective patient;<br/><hr>152&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(III)  providing medical treatment or medical advice to the current or prospective<br/>153&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;patient; or<br/>154&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(IV)  determining whether the current or prospective patient:<br/>155&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Aa)  is attempting to fraudulently obtain a controlled substance from the practitioner;<br/>156&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or<br/>157&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Bb)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled<br/>158&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance from the practitioner;<br/>159&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (A)  relates specifically to a former patient of the practitioner; and<br/>160&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  is provided to or sought by the practitioner for the purpose of determining whether<br/>161&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the former patient has fraudulently obtained, or has attempted to fraudulently obtain, a<br/>162&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance from the practitioner;<br/>163&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  relates specifically to an individual who has access to the practitioner's Drug<br/>164&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Enforcement Administration identification number, and the practitioner suspects that the<br/>165&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individual may have used the practitioner's Drug Enforcement Administration identification<br/>166&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;number to fraudulently acquire or prescribe a controlled substance;<br/>167&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  relates to the practitioner's own prescribing practices, except when specifically<br/>168&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prohibited by the division by administrative rule;<br/>169&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)  relates to the use of the controlled substance database by an employee of the<br/>170&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practitioner, described in Subsection (2)(g); or<br/>171&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)  relates to any use of the practitioner's Drug Enforcement Administration<br/>172&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;identification number to obtain, attempt to obtain, prescribe, or attempt to prescribe, a<br/>173&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;controlled substance;<br/>174&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)  in accordance with Subsection (3)(a), an employee of a practitioner described in<br/>175&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (2)(f), for a purpose described in Subsection (2)(f)(i) or (ii), if:<br/>176&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the employee is designated by the practitioner as an individual authorized to access<br/>177&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the information on behalf of the practitioner;<br/>178&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the practitioner provides written notice to the division of the identity of the<br/>179&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employee; and<br/>180&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the division:<br/>181&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  grants the employee access to the database; and<br/>182&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  provides the employee with a password that is unique to that employee to access<br/><hr>183&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database in order to permit the division to comply with the requirements of Subsection<br/>184&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-203">58-37f-203</a>[<strike>(3)(b)</strike>]<u>(5)</u> with respect to the employee;<br/>185&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)  an employee of the same business that employs a licensed practitioner under<br/>186&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (2)(f) if:<br/>187&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the employee is designated by the practitioner as an individual authorized to access<br/>188&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the information on behalf of the practitioner;<br/>189&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the practitioner and the employing business provide written notice to the division of<br/>190&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the identity of the designated employee; and<br/>191&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the division:<br/>192&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  grants the employee access to the database; and<br/>193&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  provides the employee with a password that is unique to that employee to access<br/>194&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database in order to permit the division to comply with the requirements of Subsection<br/>195&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-203">58-37f-203</a>[<strike>(3)(b)</strike>]<u>(5)</u> with respect to the employee;<br/>196&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  a licensed pharmacist having authority to dispense a controlled substance to the<br/>197&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;extent the information is provided or sought for the purpose of:<br/>198&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  dispensing or considering dispensing any controlled substance; or<br/>199&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  determining whether a person:<br/>200&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  is attempting to fraudulently obtain a controlled substance from the pharmacist; or<br/>201&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  has fraudulently obtained, or attempted to fraudulently obtain, a controlled<br/>202&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;substance from the pharmacist;<br/>203&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)  in accordance with Subsection (3)(a), a licensed pharmacy technician who is an<br/>204&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employee of a pharmacy as defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-102&session=2015GS">58-17b-102</a>, for the purposes described in<br/>205&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (2)(h)(i) or (ii), if:<br/>206&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the employee is designated by the pharmacist-in-charge as an individual authorized<br/>207&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to access the information on behalf of a licensed pharmacist employed by the pharmacy;<br/>208&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the pharmacist-in-charge provides written notice to the division of the identity of<br/>209&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the employee; and<br/>210&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the division:<br/>211&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  grants the employee access to the database; and<br/>212&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  provides the employee with a password that is unique to that employee to access<br/>213&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database in order to permit the division to comply with the requirements of Subsection<br/><hr>214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-203">58-37f-203</a>[<strike>(3)(b)</strike>]<u>(5)</u> with respect to the employee;<br/>215&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)  federal, state, and local law enforcement authorities, and state and local<br/>216&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prosecutors, engaged as a specified duty of their employment in enforcing laws:<br/>217&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  regulating controlled substances;<br/>218&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  investigating insurance fraud, Medicaid fraud, or Medicare fraud; or<br/>219&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  providing information about a criminal defendant to defense counsel, upon request<br/>220&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;during the discovery process, for the purpose of establishing a defense in a criminal case;<br/>221&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)  employees of the Office of Internal Audit and Program Integrity within the<br/>222&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Department of Health who are engaged in their specified duty of ensuring Medicaid program<br/>223&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;integrity under Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-18-2.3&session=2015GS">26-18-2.3</a>;<br/>224&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)  a mental health therapist, if:<br/>225&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the information relates to a patient who is:<br/>226&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  enrolled in a licensed substance abuse treatment program; and<br/>227&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  receiving treatment from, or under the direction of, the mental health therapist as<br/>228&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;part of the patient's participation in the licensed substance abuse treatment program described<br/>229&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in Subsection (2)(m)(i)(A);<br/>230&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the information is sought for the purpose of determining whether the patient is<br/>231&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;using a controlled substance while the patient is enrolled in the licensed substance abuse<br/>232&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;treatment program described in Subsection (2)(m)(i)(A); and<br/>233&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the licensed substance abuse treatment program described in Subsection<br/>234&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)(m)(i)(A) is associated with a practitioner who:<br/>235&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  is a physician, a physician assistant, an advance practice registered nurse, or a<br/>236&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;pharmacist; and<br/>237&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  is available to consult with the mental health therapist regarding the information<br/>238&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;obtained by the mental health therapist, under this Subsection (2)(m), from the database;<br/>239&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)  an individual who is the recipient of a controlled substance prescription entered into<br/>240&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database, upon providing evidence satisfactory to the division that the individual requesting<br/>241&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the information is in fact the individual about whom the data entry was made;<br/>242&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o)  the inspector general, or a designee of the inspector general, of the Office of<br/>243&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inspector General of Medicaid Services, for the purpose of fulfilling the duties described in<br/>244&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title 63A, Chapter 13, Part 2, Office and Powers; and<br/><hr>245&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p)  the following licensed physicians for the purpose of reviewing and offering an<br/>246&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;opinion on an individual's request for workers' compensation benefits under Title 34A, Chapter<br/>247&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2, Workers' Compensation Act, or Title 34A, Chapter 3, Utah Occupational Disease Act:<br/>248&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  a member of the medical panel described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=34a-2-601&session=2015GS">34A-2-601</a>; or<br/>249&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  a physician offering a second opinion regarding treatment.<br/>250&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) (a) (i)  A practitioner described in Subsection (2)(f) may designate up to three<br/>251&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;employees to access information from the database under Subsection (2)(g), (2)(h), or (4)(c).<br/>252&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  A pharmacist described in Subsection (2)(i) who is a pharmacist-in-charge may<br/>253&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designate up to three employees to access information from the database under Subsection<br/>254&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)(j).<br/>255&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  The division shall make rules, in accordance with Title 63G, Chapter 3, Utah<br/>256&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administrative Rulemaking Act, to:<br/>257&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  establish background check procedures to determine whether an employee<br/>258&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;designated under Subsection (2)(g), (2)(h), or (4)(c) should be granted access to the database;<br/>259&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and<br/>260&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  establish the information to be provided by an emergency room employee under<br/>261&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (4).<br/>262&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  The division shall grant an employee designated under Subsection (2)(g), (2)(h), or<br/>263&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)(c) access to the database, unless the division determines, based on a background check, that<br/>264&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the employee poses a security risk to the information contained in the database.<br/>265&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) (a)  An individual who is employed in the emergency room of a hospital may<br/>266&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exercise access to the database under this Subsection (4) on behalf of a licensed practitioner if<br/>267&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the individual is designated under Subsection (4)(c) and the licensed practitioner:<br/>268&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  is employed in the emergency room;<br/>269&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  is treating an emergency room patient for an emergency medical condition; and<br/>270&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  requests that an individual employed in the emergency room and designated under<br/>271&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subsection (4)(c) obtain information regarding the patient from the database as needed in the<br/>272&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;course of treatment.<br/>273&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  The emergency room employee obtaining information from the database shall,<br/>274&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;when gaining access to the database, provide to the database the name and any additional<br/>275&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;identifiers regarding the requesting practitioner as required by division administrative rule<br/><hr>276&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;established under Subsection (3)(b).<br/>277&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  An individual employed in the emergency room under this Subsection (4) may<br/>278&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;obtain information from the database as provided in Subsection (4)(a) if:<br/>279&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the employee is designated by the practitioner as an individual authorized to access<br/>280&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the information on behalf of the practitioner;<br/>281&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the practitioner and the hospital operating the emergency room provide written<br/>282&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;notice to the division of the identity of the designated employee; and<br/>283&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the division:<br/>284&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  grants the employee access to the database; and<br/>285&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  provides the employee with a password that is unique to that employee to access<br/>286&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the database in order to permit the division to comply with the requirements of Subsection<br/>287&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-203">58-37f-203</a>[<strike>(3)(b)</strike>]<u>(5)</u> with respect to the employee.<br/>288&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  The division may impose a fee, in accordance with Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63j-1-504&session=2015GS">63J-1-504</a>, on a<br/>289&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;practitioner who designates an employee under Subsection (2)(g), (2)(h), or (4)(c) to pay for the<br/>290&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;costs incurred by the division to conduct the background check and make the determination<br/>291&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;described in Subsection (3)(b).<br/>292&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) (a)  An individual who is granted access to the database based on the fact that the<br/>293&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individual is a licensed practitioner or a mental health therapist shall be denied access to the<br/>294&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;database when the individual is no longer licensed.<br/>295&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  An individual who is granted access to the database based on the fact that the<br/>296&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;individual is a designated employee of a licensed practitioner shall be denied access to the<br/>297&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;database when the practitioner is no longer licensed.<br/>298&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.  Section <b>58-37f-501</b><a name="58-37f-501"></a> is amended to read:<br/>299&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>58-37f-501.</b>   <b>Costs of operating database and recording, submitting, and accessing</b><br/>300&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>information.</b><br/>301&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)  All department and division costs necessary to establish and operate the database<br/>302&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall be funded by appropriations from:<br/>303&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  the Commerce Service Account; and<br/>304&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  the General Fund.<br/>305&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)  All costs associated with recording and submitting [<strike>data</strike>] <u>information</u> as required in<br/>306&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;this chapter shall be assumed by the submitting pharmacy.<br/><hr>307&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3)  All costs associated with accessing the information contained in the controlled</u><br/>308&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>substance database shall be assumed by the accessing pharmacy, pharmaceutical facility, or</u><br/>309&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>prescribing practitioner.</u><br/>310&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4. <b>Repealer.</b><br/>311&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill repeals:<br/>312&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <b><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37f-801&session=2015GS">58-37f-801</a>,</b> <b>Pilot program for real-time reporting for controlled substance</b><br/>313&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>database -- Statewide implementation.</b><br/>314&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.  <b>Appropriation.</b><br/>315&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Under the terms and conditions of Title 63J, Chapter 1, Budgetary Procedures Act, for</u><br/>316&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the fiscal year beginning July 1, 2015, and ending June 30, 2016, the following sums of money</u><br/>317&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>are appropriated from resources not otherwise appropriated, or reduced from amounts</u><br/>318&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>previously appropriated, out of the funds or accounts indicated.  These sums of money are in</u><br/>319&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>addition to any amounts previously appropriated for fiscal year 2016.</u><br/>320&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>To Department of Commerce - Division of Occupational and Professional Licensing</u><br/>321&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>From General Fund<div align="right">$46,000</u></div><br/>322&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule of Programs:</u><br/>323&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Controlled Substance Database&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$46,000</u><br/>324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.  <b>Effective date.</b><br/>325&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This bill takes effect on July 1, 2015.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of   2-23-15  4:33 PM</b><br/><br/><div align="right"><b>Office of Legislative Research and General Counsel</b></div>
</font>
</div>
</body>
</html>
